- There were around 44,500 new cases of lung cancer in the UK in 2012, that’s around 122 people every day.
- Lung cancer is the second most common cancer in the UK after breast cancer (2012).
- Lung cancer accounts for 13% of all new cases in the UK (2012).
- In men, lung cancer is the second most common cancer in the UK, with around 24,000 cases diagnosed in 2012.
- In women, lung cancer is the second most common cancer in the UK, with around 20,500 cases diagnosed in 2012.
- More than 4 in 10 (43%) cases of lung cancer are diagnosed in people aged 75 and over.
- Rates of lung cancer in Scotland are among the highest in the world, reflecting the history of high smoking prevalence there.
- Lung cancer incidence rates in men peaked in the late 1970s and since then have decreased by 45%. This reflects the decline in smoking rates in men since around the end of the 1940s.
- Lung cancer incidence rates in women have increased by 64% since the late 1970s. This reflects the increase in smoking rates in women between World War II and the 1970s.
- Most lung cancer cases are diagnosed at a late stage.
- In Europe, more than 410,000 new cases of lung cancer were estimated to have been diagnosed in 2012. The UK incidence rate is seventh lowest in Europe for males and seventh highest for females.
- Worldwide, nearly 1.83 million new cases of lung cancer were estimated to have been diagnosed in 2012, with incidence rates varying across the world.
- 1 in 13 men and 1 in 17 women will be diagnosed with lung cancer during their lifetime.
Lung cancer statistics
New cases of lung cancer, 2012, UK
Deaths from lung cancer, 2012, UK
Survive lung cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of lung cancer, UK
- Lung cancer is the most common cause of cancer death in the UK, accounting for more than 1 in 5 cancer deaths.
- Around 35,400 people died from lung cancer in the UK in 2012, that’s 97 people every day.
- Almost half of people who die from lung cancer are aged 75 or over.
- Lung cancer mortality rates for men in the UK have more than halved since the 1970s. For females, the mortality rate increased by 60% between the early 1970s and the late 1980s. Since then, rates have increased more slowly. These variations reflect past smoking behaviour.
- In Europe, nearly 354,000 people were estimated to have died from lung cancer in 2012. The UK mortality rate is 11th lowest in Europe for males and fifth highest for females.
- Worldwide around 1.59 million people were estimated to have died from lung cancer in 2012, with mortality rates varying across the world.
- 5 in 100 (5%) of people diagnosed with lung cancer in England and Wales survive their disease for ten years or more (2010-11).
- A tenth (10%) of people diagnosed with lung cancer in England and Wales survive their disease for five years or more (2010-11).
- Around a third (32%) of people diagnosed with lung cancer in England and Wales survive their disease for one year or more (2010-11).
- Lung cancer survival is higher in women than men at one- and five-years but similar at ten-years.
- Lung cancer survival is highest for people diagnosed aged under 40 years old.
- Around 4 in 10 people diagnosed aged 15-39 survive their disease for five years or more, compared with 5 in 100 people diagnosed aged 80 and over.
- Lung cancer survival has not shown much improvement in the last 40 years in the UK.
- In the 1970s, less than 5 in 100 people diagnosed with lung cancer survived their disease beyond ten years, now it's 5 in 100.
- When diagnosed at its earliest stage, more than a third of people with lung cancer will survive their disease for five years or more, compared with around 5 in 100 of people when diagnosed at a later stage.
- 89% (91% in males and 87% in females) of lung cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- A person’s risk of developing lung cancer depends on many factors, including age,genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- Smoking is the main avoidable risk factor for lung cancer, linked to an estimated 86% of lung cancer cases in the UK.
- An estimated 89% of lung cancers in the UK are linked to lifestyle factors including smoking, certain occupational exposures (13%), and ionising radiation (5%).
- Environmental tobacco smoke, ionising radiation, air pollution, and diesel engine exhaust cause lung cancer.
- A diet high in fruit and vegetables may protect against lung cancer – insufficient fruit and vegetables intake is linked to an estimated 9% of lung cancer cases in the UK.
- Emergency presentation is the most common route to diagnosis of lung cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for lung cancer.
- A tenth of lung cancer patients receive major surgical resection as part of their cancer treatment.
- Around 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- 9 in 10 patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for lung cancer in the UK are; incidence 2012, mortality 2012 and survival 2010-2011.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Lung cancer is part of the group 'Lung cancer' for cancer waiting times data. Codes vary per country but broadly include: trachea, bronchus and lung, thymus, heart, mediastinum and pleura, other and ill-defined sites of the respiratory system, mesothelioma, secondary cancers of the mediastinum, pleura or other and unspecified respiratory organs.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.